Scholarlink

Background <p>The increasing prevalence of obesity represents a&#xa0;significant and growing challenge in orthopaedic surgery. This is particularly true for patients with morbid obesity, who have a&#xa0;significantly increased risk of postoperative complications. The newer incretin-based therapies (such as semaglutide and tirzepatide), these so-called “weight loss injections”, offer promising potential for preoperative weight reduction and minimisation of peri- and postoperative complications.</p> Study situation <p>However, the evidence regarding their influence on postoperative outcomes is inconsistent. Retrospective studies suggest that rapid weight loss immediately prior to orthopaedic surgery may increase the risk of complications, including septic shock and revision surgery. Meta-analyses, on the other hand, indicate potential protective effects in surgical outcomes with prior long-term weight reduction.</p> Conclusion <p>There are currently no sufficiently qualitative studies on the safety and efficacy of these new drugs in the orthopaedic surgery sector. An individualised and multidisciplinary approach, therefore, remains relevant in order to achieve an optimal surgical outcome for the individual patient.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Die Abnehmspritze: Sinn oder Unsinn präoperativ?

  • 期刊论文

  • 发表日期：

    2025年2月3日

查看全文
  • Saif Al Basri,
  • Wiebke K. Fenske

摘要

Background

The increasing prevalence of obesity represents a significant and growing challenge in orthopaedic surgery. This is particularly true for patients with morbid obesity, who have a significantly increased risk of postoperative complications. The newer incretin-based therapies (such as semaglutide and tirzepatide), these so-called “weight loss injections”, offer promising potential for preoperative weight reduction and minimisation of peri- and postoperative complications.

Study situation

However, the evidence regarding their influence on postoperative outcomes is inconsistent. Retrospective studies suggest that rapid weight loss immediately prior to orthopaedic surgery may increase the risk of complications, including septic shock and revision surgery. Meta-analyses, on the other hand, indicate potential protective effects in surgical outcomes with prior long-term weight reduction.

Conclusion

There are currently no sufficiently qualitative studies on the safety and efficacy of these new drugs in the orthopaedic surgery sector. An individualised and multidisciplinary approach, therefore, remains relevant in order to achieve an optimal surgical outcome for the individual patient.